BioCorRx Inc. (OTCMKTS:BICX) Sees Significant Decline in Short Interest

BioCorRx Inc. (OTCMKTS:BICX) was the recipient of a large drop in short interest in the month of September. As of September 15th, there was short interest totalling 400 shares, a drop of 33.3% from the August 31st total of 600 shares. Based on an average trading volume of 900 shares, the short-interest ratio is currently 0.4 days.

BioCorRx Price Performance

Shares of BICX remained flat at $0.32 during midday trading on Friday. The stock had a trading volume of 200 shares, compared to its average volume of 1,747. BioCorRx has a one year low of $0.28 and a one year high of $1.68. The company’s 50 day moving average price is $0.39 and its two-hundred day moving average price is $0.65. The company has a market cap of $3.13 million, a PE ratio of -0.70 and a beta of 0.59.

BioCorRx (OTCMKTS:BICX) last issued its quarterly earnings data on Tuesday, August 13th. The company reported ($0.13) earnings per share for the quarter.

About BioCorRx

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.